You can use this website to find out the number of deaths, disabilities and illnesses associated with your particular batch code. The sheer number of deaths and disabilities is cause for concern – far exceeding the adverse events associated with flu vaccine lots of equal size.
Jacinda Ardern Promotes a ‘Vaxathon’, as the Jab is injuring and killing New Zealanders
This is a must hear warning to all high school, college & professional athletes and coaches: YOU ARE BEING PLAYED. Don’t let them get away with it.
LifeSite hosted a townhall conference with The Truth For Health Foundation, “Stop the Shot… The Rest of the Story”.
Session III: First Do No Harm with Michael Palmer and fellow lead scientists Sucharit Bhakdi and Mike Yeadon. The complicit role of the media and the drive for control through deployment of vaccination passports, with Taylor Hudak, Michael Meyen, Patrick Henningsen and his guests
We’ve been through a year and a half of enormous stress. Now it’s required of us to stand up and take action to save the future of the human race.
With a “vaccine” based on untested technology, and safety trials still ongoing, is it safe to take the shot? And does it even work? And does a disease with an IFR of 0.2% even justify that risk?
The vaccine contains a spike protein called syncytin-1, vital for the formation of human placenta in women.
It just gets worse! The vaccine contains a spike protein called syncytin-1, vital for the...
This petition for a stay of action is submitted by the undersigned (“Petitioner” or “Lead Petitioner”) to request the EMA a) stay the Phase III clinical trial(s) of BNT162b (EudraCT Number 2020-002641-42) in the EU (current protocol country: Germany)
In the publication entitled “Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR” (Eurosurveillance 25(8) 2020) the authors present a diagnostic workflow and RT-qPCR protocol for detection and diagnostics of 2019-nCoV (now known as SARS-CoV-2), which they claim to be validated, as well as being a robust diagnostic methodology for use in public-health laboratory settings.
Dr. Michael Yeadon is an Allergy & Respiratory Therapeutic Area expert with 23 years in the pharmaceutical industry. He trained as a biochemist and pharmacologist, obtaining his PhD from the University of Surrey (UK) in 1988.